| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.57▲ | 1.56▲ | 1.57▲ | 1.56▲ | 1.75▼ |
| MA10 | 1.57▲ | 1.57▲ | 1.58▲ | 1.68▼ | 1.87▼ |
| MA20 | 1.56▲ | 1.58▲ | 1.57▲ | 1.72▼ | 1.65▼ |
| MA50 | 1.59▼ | 1.56▲ | 1.60▼ | 1.82▼ | 1.23▲ |
| MA100 | 1.57▲ | 1.62▼ | 1.73▼ | 1.58▲ | 1.32▲ |
| MA200 | 1.56▲ | 1.74▼ | 1.76▼ | 1.25▲ | 2.54▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.004▲ | -0.002▼ | 0.003▲ | -0.026▼ | -0.033▼ |
| RSI | 57.127▲ | 53.074▲ | 50.926▲ | 44.339▼ | 50.448▲ |
| STOCH | 72.083 | 37.870 | 18.536▼ | 11.242▼ | 42.443 |
| WILL %R | -10.000▲ | -65.385 | -65.385 | -83.333▼ | -66.858 |
| CCI | 131.347▲ | 10.853 | -0.886 | -86.589 | -64.658 |
| CDL | $IOBT Hammer Candlestick Pattern Detected | Set Alert |
|
Tuesday, September 23, 2025 05:20 AM
Oral presentation will highlight the results from the randomized Phase 3 trial (IOB-013/KN-D18) of IO102-IO103 cancer vaccine plus pembrolizumab for first-line (1L) advanced melanomaPoster ...
|
|
Tuesday, September 09, 2025 08:41 AM
IO Biotech, Inc. ( NASDAQ: IOBT) Morgan Stanley 23rd Annual Global Healthcare Conference September 9, 2025 7:45 AM EDT ...
|
|
Thursday, September 04, 2025 01:05 AM
NEW YORK, Sept. 04, 2025 (GLOBE NEWSWIRE) -- IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, immune-modulatory, off-the-shelf therapeutic cancer vaccines, ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 25/09/25 | 1.56 | 1.595 | 1.535 | 1.58 | 525,780 |
| 24/09/25 | 1.60 | 1.67 | 1.55 | 1.58 | 1,281,110 |
| 23/09/25 | 1.54 | 1.63 | 1.51 | 1.60 | 1,693,185 |
| 22/09/25 | 1.57 | 1.60 | 1.48 | 1.49 | 805,670 |
| 19/09/25 | 1.65 | 1.655 | 1.53 | 1.56 | 1,628,334 |
| 18/09/25 | 1.735 | 1.78 | 1.59 | 1.62 | 1,745,294 |
| 17/09/25 | 1.74 | 1.7999 | 1.70 | 1.71 | 943,491 |
| 16/09/25 | 1.81 | 1.83 | 1.71 | 1.72 | 1,405,446 |
| 15/09/25 | 2.05 | 2.05 | 1.8013 | 1.84 | 1,271,399 |
| 12/09/25 | 1.90 | 2.08 | 1.90 | 2.08 | 1,120,400 |
|
|
||||
|
|
||||
|
|